Clinical implications of circulating soluble Fas and Fas ligand in patients with acute myocardial infarction

Coronary Artery Disease

Volumn 10, Issue 4, 1999, Pages 221-225

  Ohtsuka, Tomoaki ^a   Hamada, Mareomi ^a   Sasaki, Osamu ^a   Suzuki, Makoto ^a   Hara, Yuji ^a   Shigematsu, Yuji ^a   Ohtani, Takashi ^b   Honda, Toshio ^b   Hiwada, Kunio ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saiseikai Saijo Hospital   (Japan)

Author keywords

Acute myocardial infarction; Apoptosis; Coronary artery disease; Fas ligand; Soluble Fas

Indexed keywords

CREATINE KINASE; FAS ANTIGEN; FAS LIGAND; MYOSIN LIGHT CHAIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; APOPTOSIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; DEVICE; FEMALE; HEART CATHETERIZATION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HUMAN; HUMAN TISSUE; LUNG WEDGE PRESSURE; MALE; PRIORITY JOURNAL;

EID: 0032767119     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199906000-00003     Document Type: Article

References (22)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
2. Searle J, Kerr JFR, Bishop CJ. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu 1982; 17:229-259.
3. Buja LM, Eigenbrodt ML, Eigenbrodt EH. Apoptosis and necrosis: basic types and mechanisms of cell death. Arch Pathol Lab Med 1993; 117:1208-1214.
4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-1462.
5. Itoh N, Yonehara S, Ishii A. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-243.
6. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263:1759-1762.
7. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75:1169-1178.
8. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994; 75:426-433.
9. Gottlieb RA, Burleson KA, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94:1621-1628.
10. Nishigaki K, Minatoguchi S, Seishima M, Asano K, Noda T, Yasuda N, et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 1997; 29:1214-1220.
11. Okumura M, Yamaguchi S, Nozaki N, Yamaoka M, Shirakabe M, Tomoike H. Serum levels of soluble form of Fas molecule in patients with congestive heart disease. Am J Cardiol 1997; 79:1698-1701.
12. Toyozaki T, Hiroe M, Saito T, Iijima Y, Takano H, Hiroshima K, et al. Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers. Am J Cardiol 1998; 81:798-800.
13. Tomokuni A, Aikoh T, Matsuki T, Isozaki Y, Otsuki T, Kita S, et al. Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin Exp Immunol 1997; 110:303-309.
14. Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. J Am Coll Cardiol 1992; 19:248-257.
15. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335:1182-1189.
16. James TN, Martin ES, Willis PW, Lohr TO. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation 1996; 93:1424-1438.
17. Piot CA, Padmanaban D, Ursell PC, Sievers RE, Wolfe CL. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation 1997; 96:1598-1604.
18. Chen C, Ma L, Linfert DR, Lai T, Fallon JT, Gillam LD, et al. Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol 1997; 30:1407-1412.
19. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997; 95:320-323.
20. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996; 74:86-107.
21. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148:1274-1279.
22. Kawakami H, Shigematsu Y, Ohtsuka T, Okayama H, Hayashi Y, Hara Y, et al. Increased circulating soluble form of Fas in patients with dilated cardiomyopathy. Jpn Circ J 1998; 62:873-876.